Tom Civik
Tom Civik has been appointed as chief commercial officer of Foundation Medicine and will start his new position in mid November. Most recently, he was a vice president and franchise leader at Genentech, where he was responsible for several oncology products. Earlier, he held various commercial positions at Sanofi-Synthelabo. Civik holds a BA from St. Norbert College and a master's degree in business administration from the Kellogg School of Management at Northwestern University.
Thomas Grogan
Thomas Grogan has joined the board of directors of ReadCoor. He is professor emeritus of pathology at the University of Arizona College of Medicine and a scientific advisor to Ventana Medical Systems, which he founded, and Roche Tissue Diagnostics.
Greg Yap
Greg Yap is joining Menlo Ventures as a partner to lead investments in health, medical, and life science technologies. Yap was most recently an entrepreneur-in-residence at Illumina Ventures, where he focused on new genomics investments, and also co-founded and served as CEO of PyrAmes, a digital health company. Previously Yap was CEO and co-founder of protein analysis firm Biodesy. He has also held senior roles at Roche/Ventana and Affymetrix.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.